About the Conference
The Toxicities of Transplantation and Cellular Therapies Conference brings together experts and thought leaders from around the world to discuss the mechanism of toxicities and symptom burden after hematopoietic cell transplantation (HCT) and cellular and gene therapies; current advances in the field; and best practices to both prevent and treat these toxicities and symptoms.
The program will include a wide range of pre-clinical, translational and clinical topics, will offer networking opportunities and a dedicated poster reception showcasing research in toxicities.
The Toxicities Conference will return in fall 2026.
Who Should Attend
Physicians, advanced practice providers, and nurses who treat or refer patients for HCT or immune effector cell therapies.
Key Information
Topics include:
- Acute, late, and potentially underrepresented toxicities of transplantation, CAR T, and gene therapies.
- Enhancing health resilience and well-being in our transplantation and cellular therapy patients through nutrition, exercise science, and integrative medicine.
- Novel approaches to improve the outcomes of transplantation and CAR T therapy in older patients.
- New approaches incorporating machine learning for prediction and detection of toxicities to allow for earlier intervention.
- Understanding the interaction between the choice GVHD prophylaxis and toxicities after allo-HCT in the era of PTCy.
- Unique toxicity considerations in patients receiving cellular therapies for solid organ malignancies.